According to Research by SNS Insider, U.S. Multiple Myeloma Market is projected to reach USD 13.91 Billion by 2032, as novel drug classes, immunotherapies, and diagnostic advances reshape treatment ...

Researchers sought to determine whether subcutaneous isatuximab would be effective for patients with newly diagnosed MM who are ineligible for transplantation.

Cancer survival has doubled in the past half a century, but around 167,000 people still die of the disease in the UK every ...

Knowable Magazine reports that studying dogs' cancers offers insights into human cancer, due to similar pathways and faster ...